Assignment: The Use of Protein NMR in Active SiteMapping.NuclearMagnetic resonance spectroscopy (NMR) is an analytical technique that is basedon using the known chemical constituent of a compound to distinguish it fromother unknown compounds. The ability of this technique to distinguish thedifference in molecular structure of substances and the information it providesabout the dynamics and interactions of molecule in the smallest possible unitof a matter makes it an indispensable tool in the process drug discovery,development and delivery. This chemical analytical method is very sensitive toits environment, so can give very minute information about how the smallestfragment of a molecule binds to a target molecule, protein or its complexes.Information about the exact binding site or interaction between the fragmentand the receptor of interest is also highlighted. Hence, this technique is avery vital technique in the Pharmaceutical, forensic, quality control industry.
This analytic technique also has its application in the field of research whereit is used to determine the purity, quality, quantity and structure of theunknown while confirming that of the known substance. The combination of thisanalytical chemistry technique to Protein in the biological science is what isknown as Protein NMR. IntroductionProteinNuclear Magnetic Resonance has been used extensively to study enzymemechanisms, analyzing structures of proteins, nucleic acid and its complexes Thistechnique is also employed in studying protein ligand /protein interactions andthe dynamics of protein. In the field of drug development, the study of proteinand its complexes are of utmost importance as they play vital role inphysiological and pathological conditions and process hence the importance of thoroughlyunderstanding their catalytic process and how they bind to their substrate. ProteinNMR in active site mapping thus, is the application of NMR in the region of anenzyme where substrate molecules bind and undergo chemical reaction as well aswhere its residues forms temporary chemical bonds with the substrate. Thisregion in an enzyme is known as the active site.
The mapping of active sites isquite crucial in the field of pharmaceutical science or drug discovery. Thedetailed knowledge of the site of a target receptor for drug discovery and theunderstanding of the protein dynamics in the targeted site will maximize theefficacy of the proposed drug by giving a clear and precise understanding ofthe protein -ligand binding information and protein-ligand/protein interaction(Yan Li et al,2017). These interactions aid the design of new drugs forinstance enzyme inhibitors, by providing in depth details of the size on theactive sites, how many subsides are present, their properties, how they cometogether and bind chemically. The understanding of this unique interaction isalso a tool for comparison in active site mapping, where it is employed to compareprotein active sites and their structures in more details so as to design drugsthat can exactly match into the enzyme substrate complex using the key and lockanalogue for enzymes.
Thisprotein analytical tool has been used in lots of studies to investigate enzyme behaviors,their mechanisms as it takes less time an effort to acquire structuralinformation of compounds and DNA when compared to other methods like X-raycrystallography, florescence and IR spectroscopy, hence the ever-growingimportance of active site mapping using Protein NMR. (Yong et al.2012)19FNMRstudies has be done to clearly distinguish structural and functional featuresof protein as seen in its recentapplication in active site mapping out of galactose binding- protein,transmembrane aspartate receptor, the Che – Y protein dihydrofolate reductase ,elongation factor-TU, and D-lactose dehydrogenase, that demonstrate the utilityof 19 F NMR in the analysis of protein conformation state even in particles that are so large orunstable for full NMR structuredetermination.(Mark A.
D, et al 2010).Thesekind of studies depends on the chemical shift pattern of FNMR as this method isvery sensitive to change in its environment due to the presence of fluorine 19,as well as the existing weak Vander Waal force of bond as well as the presenceof the local electrostatic field. Figure 1. Overview of applications of NMR in drug discovery NMRspectroscopy can provide critical information at early stages of hit validationand identification. NMR measurements for binding studies can represent a keystep to eliminate false positives from high-throughput (HTS) campaigns, tovalidate putative hits from in silico screensor to identify novel scaffolds in fragment-based programmed. NMR and X-raycrystallography can also provide unique information to subsequently guidehit-to-lead optimization.
ADME-tox, absorption, distribution, metabolism,excretion and toxicity (Pellecchia M el at: 2002) Thisreview will mainly concentrate on saturation transfer difference (STD – NMR)method which is a solution state nuclear magnetic resonance spectroscopy techniqueused in target- based drug discovery, hit identification, validation and leadoptimization which is a tool that is extensively utilized in drug developmentprocesses as seen in our review of this method in the biological studies of newurease inhibitors. Fig2 flowchartshowing drug discovery process Fig3 showing the process in Protein NMR Process Figure 11. This is a flow chart showing the different level ofapplication of NMR in the process of drug discovery from when the target is identifiedthrough the whole complete process and the role it playshighlighted in white and blue; Figure 111, highlights the various stepsinvolved in using protein NMR in active drug in drug discovery and its application.(Yan Li et al, 2017;). Materialsand Sample preparation STD-NMR ExperimentJack bean (Canavaliaensiformis) urease (EC 220.127.116.11), urea, Dulbecco’s Modified Eagle Medium (DME),cycloheximide, di-sodium hydrogen phosphate, mono-sodium di-hydrogen phosphateUnichem (India).
Mous, and phenol were obtained from Sigma-Aldrich (USA).Deuterated methanol (CD3OD), and deuterium oxide (D2O) were purchased from the ArmarChemical (Switzerland) Methods/ExperimentalThemeasurement of urease inhibitory activity by STD- NMR technique was done usingthe afore mentioned technique, that is very popular in drug discovery andpossess high sensitivity hence often used for ligand –observed NMR screeningmethods. In this experiment, Gaussian RF pulse was applied to the most up fieldprotons of the target protein which when saturated is then transferred throughoutthe molecule by spin diffusion. At the final stage of this process the boundligands received magnetization through cross relaxation and enhanced signalintensity is displayed (Atia-tul_Wahab et al.2013:).
The sample for thisexperimental process is prepared with Jack bean (Canavalia ensiformis, EC3.5,1.5) using deuterated NMR buffer toprepare(20uM) of urease solution, which is then stored at 4 °C ligands. The reaction mixture was in excess of100folds of urease concentration. They were dissolved in 13.3% of CD3OD, and 86.7%deuterated phosphate buffer (4 mM, pH 6.
8). This was followed by STD-NMR screeningexperiment performed on Bruker 400MHZ NMR spectroscopy at 298K Stddiffgp19pulse program was used for STD-NMR experiments. Saturation time was 1.0–2.
0s,while interpulse delay (D1) was the same as D20 or D20 + 1. Loop counter was8.0 and 4.0. STD-NMRspectra were recorded with 32 scans (NS), and eight dummy scans.
For eachexperiment, 90° pulse was calibrated separately. Gaussian selective pulses of48ms length with an excitation bandwidth of 140 Hz, separated by 1 mms delayswere used. To saturate the protein selectively, on-resonance irradiation wasprovided from 0 to ?1 ppm (protein resonances), while off-resonance irradiationwas provided at 30 ppm. Difference spectrum was obtained by subtracting theon-resonance irradiation spectrum from off- resonance spectrum. This wasfollowed by docking studies that involve the study of the molecules present andhow they interact with each other so as to establish their identity, molecularstructure and how they bind to the proteins present.
These facts highlight thekind of inhibition and the kind of interaction that is existing between theligand and the protein at the atomic level (Scopes 2002;) (Meng et al,2011;). Experimental For F-NMRTechnique Purification of thetarget protein is usually the first step, followed by the modification of theprotein of target by using compounds containing fluorine like 2 bromo-N-(-4 – trifluoromethyl) phenyl)acetamide(BTFMA) at cysteine residue which results in the presence of a protein withactive “F spin ( Horst et al, 2013;) (Kitevski et al,2012:) ( Liu J, J et el, 2012;) making it possible forchemical analysis to be carried out , which is normally the last step beforethe process of Hit identification. (Nortonet al, 2016;)Hit identification iscarried out at this stage to for screening F- labeled compound using ligand – observedexperience known as FBDD, that usually has an existing library or in theabsence of this library one can easily be made-up by adopting similar rules to those use in usual fragmentlibrary to sustain ligand size and chemical variations.
F- NMR as a targetbased protein spectroscopy can be used to affirm the hit screening from HTScampaigns in which a chemical assay has being used as the primary screen (Gee C.Tet al, 2016:). The proteins of targets, which are normally close to the activesite, are labeled with Fluorine atom. This technique is then preceded with theidentification and validation of the targeted resonance in the presence of thefluorinated substrate.
Results:In this review we havelooked at the use of protein NMR in active site mapping by using biochemicalassay, then followed by the use of STD-NMR which is a ligand resonance based technique,for the primary identification of urease inhibitors. Then followed by moleculardocking studies to validate the biochemical experiment as well as to estimatethe relative binding affinity between the ligand and receptor. F-NMR which is atarget based resonance, coupled with hit identification methods were also useto observe targeted ligand, screening were carried out, confirmation of theprimary screen with the use of the F atom and its identification and validationin the presence of the fluorinated substrate was achieved in this experimentDiscussion;Themeasurement of urease inhibitory activity by STD- NMR technique was done using Saturationtransfer differential NMR which is a ligand resonance based spectroscopicmethod that is undoubtedly one of the most widely used NMR Spectroscopic techniquedue to it’s ability to establish a binding relationship between the inhibitorsand protein as seen in this experiment. This technique uses the advantage of theability of the protons of the inhibitors which are in close contact to thetarget protein so receive high value of Rf saturation hence promotingdifferential signal in STN-NMR spectroscopy hence displaying this signalreceived from the environment with great intensity between receptor protein andligand molecule. This is an edge that the ligand resonance spectroscopictechnique have over the target based NMR technique as this method explores theproximity of the inhibitors to the protein and the intense signals generated tomake deduction we were able to established from this experiment that the wholemolecules were interacting with the enzymes (Jalaluddin A.et al 2017:). ligandNMR as seen in this study, tend to observe signals from ligands, no isotopiclabeling is required for target protein, thus experimental method takes lesstime than target based NMR method and can be used to determine dissociationconstant either using titration experiment or be observation of changes in thewidth of a ligand induced by protein binding (Yan Li et al.
2017;).The Dockingstudies was able to affirm enzyme inhibitory activities F- NMRexperimental on the other hand is a target based method employed for theinvestigating of protein-ligand binding interactions in drug delivery mainlyuse in fragment screening, as the 19F nucleus has a natural abundance of100%(83% of the sensitivity of 1H) and a massive chemical shift of dispersion(Didenko, J t et al, 2013;). Since “F- atom is not naturally present in biologicalsystems, which means there will not be any background signal observed ordetected (Horst .R. et al, 2013:) (Kitevski – LeBlanc J.
L et al, 2012: ) (Liu J.Jet al, 2012:).So atarget protein was first labeled in the bacteria system by adding 19F– labeledamino acid in the culture medium, then purified after which it is modified byusing 2-bromo-N-(-4-(trifluoromethyl) phenyl) acetamide (BTFMA) resulting in avery rapid 19F spin and because it is ligand resonance spectroscopy a 19f atomwas introduced in the ligand to enable its observation through chemical analysis due to the 19F atom’s chemical shift being very sensitive to itsenvironment and the changes that occurs in it as a result of the weak Dan Der Waals bond and the presence of electrostatic field (Didenko T.
et al, 2013:) Hit-identification steps is then adopted to identify, screen and validate theinhibitor as it is a very sensitive technique that is able to break downcompounds with similar structures to aid their detection by comparing thechemical shift change. The hit identification step was carried out using F-NMR methodas this technique is also use for this purpose in fragment base drug deliveryin three different ways, which are; the comparison of the 19f-labelled compoundwith libraries of available ligand –observed experiment with the aim ofscreening the19F- labeled compound against libraries of available screenedcompounds to establish the ligand size and chemical diversity with the view ofusing it for further development. More so, as biomedical assays are mainly use forprimary screen in protein NMR active site mapping, this method is then employedto confirm hits screens from HTS campaigns (Gee C.T, et l 2016:) as the19f-labeled target is distinguish from every other compound present in thenormal HTS library as they all do not possess 19F-labelling and in this systemof identification the residue from the labeled atom is usually close to theactive site to enable structural and biochemical characteristic to be studied, the presence of a fluorinated compound makes ease of studyof substrate by the use of F-NMR methodThisassay is design in such a way that the changes of the substrate on breakingdown must be carefully observed to monitor the disintegration of the targetprotein, so as to be able to record and determine its ability to test ascreened compound accurately as this is used for the hit identification andconfirmation of the fluorinated substrate.
Theadvantage of this method over the other is that even though ligand-observedexperiments cannot be use for the identification of binding site this methodcan be used at times due to the presence of the 19F labeled atom that aids inidentification of residue that are vital for binding in the presence of 19fassigned atom. This methods of identification and confirmation also tends toproduce positive false results in ligand – observed experiments due to theproblem of non-specific interaction and aggregate effects (Zega .A, 2017;)Conclusion:Conclusively,protein NMR spectroscopy in active site mapping is an indispensable tool withwide range of application in early stage of drug discovery, through all thephases of manufacturing till it is displayed on shelf owing to its methods, suchas STD-NMR spectroscopy, and its ability to adapt molecular docking techniques toits advantage. This characteristics of this technique aids its precision indrug screening and the ease of its application as well as the fact that it doesnot require a lot of data and its less time consuming when compared to otherNMR methods employed in this field.
Furthermore, the knowledge that this methodprovides about the presence and the kind of enzyme present in a target site asseen in the study of the new urease inhibitor, the intensity of the bondbetween the active site and the inhibitor is very important for the formationand design of new drug, hence aids in producing drugs that binds to its receptor and exert a physiological effect as well ashighlighting Professionals on pathological issues.